/Danaher%20Corp_%20logo%20on%20vial-by%20Melnilov%20Dmitriy%20via%20Shutterstock.jpg)
Valued at a market cap of $129.9 billion, Danaher Corporation (DHR) designs, manufactures, and markets professional, medical, research, and industrial products and services. This Washington, District Of Columbia-based global conglomerate specializes in life sciences, diagnostics, and biotechnology. It is scheduled to announce its fiscal Q1 earnings for 2025 before the market opens on Tuesday, Apr. 22.
Ahead of this event, analysts expect this healthcare company to report a profit of $1.62 per share, down 15.6% from $1.92 per share in the year-ago quarter. The company has exceeded Wall Street's earnings estimates in three of the last four quarters, while missing on another occasion. In Q4 2024, DHR’s EPS of $2.14 fell short of the forecasted figure by 1.4%.